Literature DB >> 28577335

Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.

Zhiwei Li1, Tao Ai1, Yiqi Hu1, Xu Yan2, Marcel Dominik Nickel3, Xiao Xu4, Liming Xia1.   

Abstract

PURPOSE: To investigate the application of whole-lesion histogram analysis of pharmacokinetic parameters for differentiating malignant from benign breast lesions on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
MATERIALS AND METHODS: In all, 92 women with 97 breast lesions (26 benign and 71 malignant lesions) were enrolled in this study. Patients underwent dynamic breast MRI at 3T using a prototypical CAIPIRINHA-Dixon-TWIST-VIBE (CDT-VIBE) sequence and a subsequent surgery or biopsy. Inflow rate of the agent between plasma and interstitium (Ktrans ), outflow rate of agent between interstitium and plasma (Kep ), extravascular space volume per unit volume of tissue (ve ) including mean value, 25th/50th/75th/90th percentiles, skewness, and kurtosis were then calculated based on the whole lesion. A single-sample Kolmogorov-Smirnov test, paired t-test, and receiver operating characteristic curve (ROC) analysis were used for statistical analysis.
RESULTS: Malignant breast lesions had significantly higher Ktrans , Kep , and lower ve in mean values, 25th/50th/75th/90th percentiles, and significantly higher skewness of ve than benign breast lesions (all P < 0.05). There was no significant difference in kurtosis values between malignant and benign breast lesions (all P > 0.05). The 90th percentile of Ktrans , the 90th percentile of Kep , and the 50th percentile of ve showed the greatest areas under the ROC curve (AUC) for each pharmacokinetic parameter derived from DCE-MRI. The 90th percentile of Kep achieved the highest AUC value (0.927) among all histogram-derived values.
CONCLUSION: The whole-lesion histogram analysis of pharmacokinetic parameters can improve the diagnostic accuracy of breast DCE-MRI with the CDT-VIBE technique. The 90th percentile of Kep may be the best indicator in differentiation between malignant and benign breast lesions. LEVEL OF EVIDENCE: 4 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2018;47:91-96.
© 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  breast lesions; contrast-enhanced MR; histogram analysis; pharmacokinetic parameters; quantitative imaging

Mesh:

Substances:

Year:  2017        PMID: 28577335     DOI: 10.1002/jmri.25762

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  11 in total

1.  Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.

Authors:  Na-Na Sun; Xiao-Lin Ge; Xi-Sheng Liu; Lu-Lu Xu
Journal:  Radiol Med       Date:  2019-10-11       Impact factor: 3.469

2.  Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.

Authors:  Hao Xu; Jieke Liu; Zhe Chen; Chunhua Wang; Yuanyuan Liu; Min Wang; Peng Zhou; Hongbing Luo; Jing Ren
Journal:  Eur Radiol       Date:  2022-01-25       Impact factor: 5.315

3.  Assessment of quantitative dynamic contrast-enhanced MRI in distinguishing different histologic grades of breast phyllode tumor.

Authors:  Zhilong Yi; Mingwei Xie; Guangzi Shi; Ziliang Cheng; Hong Zeng; Ningyi Jiang; Zhuo Wu
Journal:  Eur Radiol       Date:  2021-09-07       Impact factor: 7.034

4.  Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.

Authors:  Kun Sun; Hong Zhu; Weimin Chai; Ying Zhan; Dominik Nickel; Robert Grimm; Caixia Fu; Fuhua Yan
Journal:  Eur Radiol       Date:  2019-08-01       Impact factor: 5.315

5.  Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI.

Authors:  Yanqiong Chen; Bin Wu; Hui Liu; Dan Wang; Yajia Gu
Journal:  J Transl Med       Date:  2018-11-23       Impact factor: 5.531

6.  Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization.

Authors:  R Elena Ochoa-Albiztegui; Varadan Sevilimedu; Joao V Horvat; Sunitha B Thakur; Thomas H Helbich; Siegfried Trattnig; Elizabeth A Morris; Jeffrey S Reiner; Katja Pinker
Journal:  Cancers (Basel)       Date:  2020-12-14       Impact factor: 6.639

7.  Radiomic features of axillary lymph nodes based on pharmacokinetic modeling DCE-MRI allow preoperative diagnosis of their metastatic status in breast cancer.

Authors:  Hong-Bing Luo; Yuan-Yuan Liu; Chun-Hua Wang; Hao-Miao Qing; Min Wang; Xin Zhang; Xiao-Yu Chen; Guo-Hui Xu; Peng Zhou; Jing Ren
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

8.  Quantitative perfusion histogram parameters of dynamic contrast-enhanced MRI to identify different pathological types of uterine leiomyoma.

Authors:  Subo Wang; Zhenhua Zhao; Yu Zhang; Liming Yang; Yanan Huang; Yawen Ruan; Cheng Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25

9.  DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.

Authors:  Serena Monti; Marco Aiello; Mariarosaria Incoronato; Anna Maria Grimaldi; Michela Moscarino; Peppino Mirabelli; Umberto Ferbo; Carlo Cavaliere; Marco Salvatore
Journal:  Contrast Media Mol Imaging       Date:  2018-01-17       Impact factor: 3.161

10.  Relationship between histogram metrics of pharmacokinetic parameters of DCE-MRI and histological phenotype in breast cancer.

Authors:  Guocai Yang; Jing Yang; Hui Xu; Qingxin Zhang; Yonghong Qi; Aiju Zhang
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.